BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26705177)

  • 21. Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review.
    Lin L; Zhang X; Dong M; Li L; Wang X; Zhang L; Fu X; Sun Z; Wu J; Li Z; Chang Y; Wang Y; Zhou Z; Zhang M; Chen Q
    Medicine (Baltimore); 2017 Feb; 96(7):e6171. PubMed ID: 28207555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal.
    Sanguedolce F; Zanelli M; Zizzo M; Martino G; Rossi C; Parente P; Ascani S
    Pathol Res Pract; 2020 Jun; 216(6):152973. PubMed ID: 32370987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
    Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
    Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Plasmablastic Lymphoma: A Rare Manifestation of HIV-Related Neoplasm-A Brief Clinical Study.
    Ramyasri M; Singh V; Mohan Rangan N; Roy ID; Tomar K; Desai AP; Yadav R; Krishnan M
    J Craniofac Surg; 2024 Jun; 35(4):e321-e325. PubMed ID: 38363301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours.
    Huettl KS; Staiger AM; Horn H; Frontzek F; Goodlad JR; Tapia G; Rosenwald A; Klapper W; Fend F; Climent F; Castellvi J; Tzankov A; Dirnhofer S; Baptista MJ; Navarro JT; Anagnostopoulos I; Hartmann W; Lenz G; Ott G
    Histopathology; 2021 May; 78(6):831-837. PubMed ID: 33165992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
    Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
    BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmablastic lymphoma mimicking carcinomatosis: A case report and review of the literature.
    Olofson AM; Loo EY; Hill PA; Liu X
    Diagn Cytopathol; 2017 Mar; 45(3):243-246. PubMed ID: 27900846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmablastic lymphoma of the gastrointestinal tract: A rare entity with a dismal prognosis.
    Komaranchath AS; Haleshappa RA; Kuntegowdenahalli LC; Kumar RV; Dasappa L; Babu G
    Indian J Cancer; 2016; 53(4):529-533. PubMed ID: 28485344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual presentation of plasmablastic lymphoma involving ovarian mature cystic teratoma: a case report.
    Hadžisejdić I; Babarović E; Vranić L; Duletić Načinović A; Lučin K; Krašević M; Jonjić N
    Diagn Pathol; 2017 Nov; 12(1):83. PubMed ID: 29187222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
    Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
    Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
    Tchernonog E; Faurie P; Coppo P; Monjanel H; Bonnet A; Algarte Génin M; Mercier M; Dupuis J; Bijou F; Herbaux C; Delmer A; Fabiani B; Besson C; Le Gouill S; Gyan E; Laurent C; Ghesquieres H; Cartron G
    Ann Oncol; 2017 Apr; 28(4):843-848. PubMed ID: 28031174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoid neoplasms of the oral cavity with plasmablastic morphology-a case series and review of the literature.
    Bhattacharyya S; Bains APS; Sykes DL; Iverson BR; Sibgatullah R; Kuklani RM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Dec; 128(6):651-659. PubMed ID: 31494113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmablastic lymphoma may occur as a high-grade transformation from plasmacytoma.
    Qing X; Sun N; Chang E; French S; Ji P; Yue C
    Exp Mol Pathol; 2011 Feb; 90(1):85-90. PubMed ID: 20969860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder.
    Liu F; Asano N; Tatematsu A; Oyama T; Kitamura K; Suzuki K; Yamamoto K; Sakamoto N; Taniwaki M; Kinoshita T; Nakamura S
    Histopathology; 2012 Dec; 61(6):1183-97. PubMed ID: 22958176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
    Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
    Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
    Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
    Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review.
    Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Silva AMB; Pontes HAR; Lopes MA; de Almeida OP; Brennan PA; Fonseca FP
    J Oral Pathol Med; 2018 Nov; 47(10):915-922. PubMed ID: 29917262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-related plasmablastic lymphoma causing extensive bone destruction in the mandible.
    Kayahara GM; Valente VB; Salzedas LMP; Passador-Santos F; Furuse C; Biasoli ÉR; Miyahara GI; Bernabé DG
    Oral Oncol; 2022 Mar; 126():105761. PubMed ID: 35151011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics and survival analysis of 15 cases of HIV-negative plasmablastic lymphoma].
    Fu WJ; He MX; Huang AJ; Gao L; Lu GH; Chen J; Chen L; Ni X; Zhang WP; Wang JM; Yang JM
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):456-461. PubMed ID: 32654457
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV-negative plasmablastic lymphoma: not in the mouth.
    Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin GA; Butera JN
    Clin Lymphoma Myeloma Leuk; 2011 Apr; 11(2):185-9. PubMed ID: 21575922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.